Molecular Mimicry of Human Endothelial Cell Antigen by Autoantibodies to Nonstructural Protein 1 of Dengue Virus

I-Ju Liu, Chien‐Yu Chiu, Yunching Chen, Han‐Chung Wu

Journal of Biological Chemistry · 2011 · 104 citations · 39 references

DOIFull text

Open access

Concepts

Abstract

The pathogenesis of dengue hemorrhagic fever and dengue shock syndrome (DHF/DSS), both serious complications of dengue virus (DV) infection, remains unclear. In this study, we found that anti-DV NS1 (nonstructural protein 1) polyclonal antibodies cross-reacted with human umbilical vein endothelial cells (HUVECs). We further identified a complex-specific mAb, DB16-1, which could recognize DV NS1 and cross-react with HUVECs and human blood vessels. The target protein of DB16-1 was further purified by immunoaffinity chromatography. LC-MS/MS analysis and co-immunoprecipitation revealed that the target protein of DB16-1 was human LYRIC (lysine-rich CEACAM1 co-isolated). Our newly generated anti-LYRIC mAbs bound to HUVECs in a pattern similar to that of DB16-1. The B-cell epitope of DB16-1 displayed a consensus motif, Lys-X-Trp-Gly (KXWG), which corresponded to amino acid residues 116–119 of DV NS1 and mimicked amino acid residues 334–337 in LYRIC. Moreover, the binding activity of DB16-1 in NS1 of DV-2 and in LYRIC disappeared after the KXWG epitope was deleted in each. In conclusion, DB16-1 targeted the same epitope in DV NS1 and LYRIC protein on human endothelial cells, suggesting that it might play a role in the pathogenesis of DHF/DSS. Future studies on the role of the anti-NS1 antibody in causing vascular permeability will undoubtedly be performed on sera collected from individuals before, during, and after the endothelial cell malfunction phase of a dengue illness. The pathogenesis of dengue hemorrhagic fever and dengue shock syndrome (DHF/DSS), both serious complications of dengue virus (DV) infection, remains unclear. In this study, we found that anti-DV NS1 (nonstructural protein 1) polyclonal antibodies cross-reacted with human umbilical vein endothelial cells (HUVECs). We further identified a complex-specific mAb, DB16-1, which could recognize DV NS1 and cross-react with HUVECs and human blood vessels. The target protein of DB16-1 was further purified by immunoaffinity chromatography. LC-MS/MS analysis and co-immunoprecipitation revealed that the target protein of DB16-1 was human LYRIC (lysine-rich CEACAM1 co-isolated). Our newly generated anti-LYRIC mAbs bound to HUVECs in a pattern similar to that of DB16-1. The B-cell epitope of DB16-1 displayed a consensus motif, Lys-X-Trp-Gly (KXWG), which corresponded to amino acid residues 116–119 of DV NS1 and mimicked amino acid residues 334–337 in LYRIC. Moreover, the binding activity of DB16-1 in NS1 of DV-2 and in LYRIC disappeared after the KXWG epitope was deleted in each. In conclusion, DB16-1 targeted the same epitope in DV NS1 and LYRIC protein on human endothelial cells, suggesting that it might play a role in the pathogenesis of DHF/DSS. Future studies on the role of the anti-NS1 antibody in causing vascular permeability will undoubtedly be performed on sera collected from individuals before, during, and after the endothelial cell malfunction phase of a dengue illness. IntroductionDengue virus (DV), 2The abbreviations used are: DV, dengue virus; DHF, dengue hemorrhagic fever; DSS, dengue shock syndrome; HUVEC, human umbilical vein endothelial cell; hCMV, human cytomegalovirus; NC, nitrocellulose; anti-Mid, anti-metadherin; NMIgG, normal mouse IgG. a flaviviridae, causes diseases ranging from mild dengue fever to severe syndromes, such as DHF and DSS (1Halstead S.B. Science. 1988; 239: 476-481Crossref PubMed Scopus (1292) Google Scholar, 2Gubler D.J. Clark G.G. Emerg. Infect. Dis. 1995; 1: 55-57Crossref PubMed Scopus (526) Google Scholar). Primary DV infection often leads to a painful but nonfatal dengue fever and protects patients from reinfection of DV of the same serotype. However, secondary infection with DV of a different serotype can trigger the more severe and potentially fatal DHF or DSS (1Halstead S.B. Science. 1988; 239: 476-481Crossref PubMed Scopus (1292) Google Scholar, 3Gubler D.J. Clin. Microbiol. Rev. 1998; 11: 480-496Crossref PubMed Google Scholar). The clinical presentations of DHF/DSS include thrombocytopenia, vascular leakage, hemorrhage, and complement activation. Because little is known about the pathogenic mechanisms underlying these disorders, no effective strategy has been developed to prevent their occurrence (4Bielefeldt-Ohmann H. Trends Microbiol. 1997; 5: 409-413Abstract Full Text PDF PubMed Scopus (48) Google Scholar, 5Halstead S.B. Lancet. 2007; 370: 1644-1652Abstract Full Text Full Text PDF PubMed Scopus (1164) Google Scholar).Several theories have been proposed to explain the pathogenesis of the DHF/DSS. One of them is antibody-dependent enhancement. It is theorized that upon the second infection by DV of different serotype, monocytes and/or macrophages enhance uptake of complexes of virus with non-neutralizing antibodies, subneutralizing cross-reactive antibodies, or low titer neutralizing antibodies through the Fc receptor (1Halstead S.B. Science. 1988; 239: 476-481Crossref PubMed Scopus (1292) Google Scholar, 6Halstead S.B. Venkateshan C.N. Gentry M.K. Larsen L.K. J. Immunol. 1984; 132: 1529-1532PubMed Google Scholar). Hence, the increased viral load induces the plasma leakage or hemorrhage in DHF/DSS. It has been proposed that host immune reactions, including complement activation, immune cell activation, cytokine production, and immune deviation, are involved in the initiation of DHF/DSS (7Kurane I. Innis B.L. Nisalak A. Hoke C. Nimmannitya S. Meager A. Ennis F.A. J. Clin. Invest. 1989; 83: 506-513Crossref PubMed Scopus (111) Google Scholar, 8Avirutnan P. Malasit P. Seliger B. Bhakdi S. Husmann M. J. Immunol. 1998; 161: 6338-6346PubMed Google Scholar, 9Gagnon S.J. Ennis F.A. Rothman A.L. J. Virol. 1999; 73: 3623-3629Crossref PubMed Google Scholar, 10Green S. Vaughn D.W. Kalayanarooj S. Nimmannitya S. Suntayakorn S. Nisalak A. Lew R. Innis B.L. Kurane I. Rothman A.L. Ennis F.A. J Infect. Dis. 1999; 179: 755-762Crossref PubMed Scopus (300) Google Scholar). Others suggest that viral virulence may play a role in the pathogenesis of DHF/DSS (11Rico-Hesse R. Harrison L.M. Salas R.A. Tovar D. Nisalak A. Ramos C. Boshell J. de Mesa M.T. Nogueira R.M. da Rosa A.T. Virology. 1997; 230: 244-251Crossref PubMed Scopus (521) Google Scholar, 12Diamond M.S. Edgil D. Roberts T.G. Lu B. Harris E. J. Virol. 2000; 74: 7814-7823Crossref PubMed Scopus (210) Google Scholar). However, although many theories have been put forward, the main mechanism underlying the development of DHF/DSS remains unknown.Several viruses have similar antigenic determinants that make them able to mimic host proteins (13Lane D.P. Hoeffler W.K. Nature. 1980; 288: 167-170Crossref PubMed Scopus (138) Google Scholar, 14Fujinami R.S. Oldstone M.B. Wroblewska Z. Frankel M.E. Koprowski H. Proc. Natl. Acad. Sci. U.S.A. 1983; 80: 2346-2350Crossref PubMed Scopus (247) Google Scholar), a phenomenon known as molecular mimicry. These viruses often initiate the generation of autoantibodies against the host's own tissues (15Query C.C. Keene J.D. Cell. 1987; 51: 211-220Abstract Full Text PDF PubMed Scopus (249) Google Scholar, 16Banki K. Maceda J. Hurley E. Ablonczy E. Mattson D.H. Szegedy L. Hung C. Perl A. Proc. Natl. Acad. Sci. U.S.A. 1992; 89: 1939-1943Crossref PubMed Scopus (147) Google Scholar, 17Lunardi C. Bason C. Navone R. Millo E. Damonte G. Corrocher R. Puccetti A. Nat. Med. 2000; 6: 1183-1186Crossref PubMed Scopus (244) Google Scholar). The presence of cross-reactive antibodies against endothelium after infection by human cytomegalovirus (hCMV), Epstein-Barr virus, and HIV is well documented (17Lunardi C. Bason C. Navone R. Millo E. Damonte G. Corrocher R. Puccetti A. Nat. Med. 2000; 6: 1183-1186Crossref PubMed Scopus (244) Google Scholar, 18Kaplan C. Morinet F. Cartron J. Semin. Hematol. 1992; 29: 34-44PubMed Google Scholar, 19Rhodes G.H. Valbracht J.R. Nguyen M.D. Vaughan J.H. J. Autoimmun. 1997; 10: 447-454Crossref PubMed Scopus (29) Google Scholar). The association of the autoantibody induced by hCMV infections and systemic sclerosis is a good example. The serum antibodies that induce endothelium apoptosis in patients of systemic sclerosis also recognize the late protein UL94 of hCMV (17Lunardi C. Bason C. Navone R. Millo E. Damonte G. Corrocher R. Puccetti A. Nat. Med. 2000; 6: 1183-1186Crossref PubMed Scopus (244) Google Scholar). The clinical onset of systemic sclerosis is associated with the generation of pathogenetic autoantibodies by chronic infection of hCMV (20Namboodiri A.M. Rocca K.M. Pandey J.P. Autoimmunity. 2004; 37: 241-244Crossref PubMed Scopus (31) Google Scholar, 21Lunardi C. Dolcino M. Peterlana D. Bason C. Navone R. Tamassia N. Beri R. Corrocher R. Puccetti A. PLoS Med. 2006; 3: e2Crossref PubMed Scopus (91) Google Scholar). However, vascular permeability and DHF/DSS in dengue is transient. Mouse polyclonal antibodies against DV-2 NS1 have been found able to cross-react with human endothelium (22Falconar A.K. Arch. Virol. 1997; 142: 897-916Crossref PubMed Scopus (219) Google Scholar, 23Lin C.F. Lei H.Y. Shiau A.L. Liu H.S. Yeh T.M. Chen S.H. Liu C.C. Chiu S.C. Lin Y.S. J. Immunol. 2002; 169: 657-664Crossref PubMed Scopus (161) Google Scholar). Moreover, serum antibodies from dengue fever and DHF patients can bind to HUVECs (23Lin C.F. Lei H.Y. Shiau A.L. Liu H.S. Yeh T.M. Chen S.H. Liu C.C. Chiu S.C. Lin Y.S. J. Immunol. 2002; 169: 657-664Crossref PubMed Scopus (161) Google Scholar, 24Lin C.F. Lei H.Y. Shiau A.L. Liu C.C. Liu H.S. Yeh T.M. Chen S.H. Lin Y.S. J. Med. Virol. 2003; 69: 82-90Crossref PubMed Scopus (162) Google Scholar). Once the binding occurs, endothelial cells undergo nitric oxide-mediated apoptosis (23Lin C.F. Lei H.Y. Shiau A.L. Liu H.S. Yeh T.M. Chen S.H. Liu C.C. Chiu S.C. Lin Y.S. J. Immunol. 2002; 169: 657-664Crossref PubMed Scopus (161) Google Scholar), an effect that can be blocked by recombinant NS1 protein (24Lin C.F. Lei H.Y. Shiau A.L. Liu C.C. Liu H.S. Yeh T.M. Chen S.H. Lin Y.S. J. Med. Virol. 2003; 69: 82-90Crossref PubMed Scopus (162) Google Scholar). Together, these findings suggest that the endothelial dysfunction caused by the induction of autoantibodies through host-virus interplay may be one of the factors in the pathogenesis of DHF/DSS. Understanding the molecular target of DV autoantibodies may, therefore, be important for diagnosis and the design of a suitable safe vaccine against this viral disease.In this study, we generated many anti-DV mAbs and successfully identified an anti-DV NS1 mAb, DB16-1, which was found to cross-react with HUVECs and human blood vessels. The protein targeted by DB16-1 was isolated by immunoprecipitation and designated LYRIC (lysine-rich CEACAM1 co-isolated), a finding further confirmed by mass spectrometry. LYRIC protein is also called metadherin (25Brown D.M. Ruoslahti E. Cancer Cell. 2004; 5: 365-374Abstract Full Text Full Text PDF PubMed Scopus (326) Google Scholar), 3D3 (26Sutherland H.G. Lam Y.W. Briers S. Lamond A.I. Bickmore W.A. Exp. Cell. Res. 2004; 294: 94-105Crossref PubMed Scopus (79) Google Scholar), or AEG-1 (astrocyte-elevated gene-1) (27Kang D.C. Su Z.Z. Sarkar D. Emdad L. Volsky D.J. Fisher P.B. Gene. 2005; 353: 8-15Crossref PubMed Scopus (246) Google Scholar) and is highly conserved between species (26Sutherland H.G. Lam Y.W. Briers S. Lamond A.I. Bickmore W.A. Exp. Cell. Res. 2004; 294: 94-105Crossref PubMed Scopus (79) Google Scholar). However, its biological function remains unclear. Using phage display to identify the B-cell epitope of DB16-1, we found that DV NS1 and LYRIC contained similar epitopes that may induce the production of an autoantibody. These findings suggest that DB16-1 might act as an autoantibody against LYRIC on endothelial cells and lead to the transient vascular leakage in DHF/DSS.DISCUSSIONThe molecular mechanisms that cause vascular leakage and hemorrhage after DV infection are not clear. There is some evidence suggesting that autoantibody binding to endothelium might be induced after DV infection (22Falconar A.K. Arch. Virol. 1997; 142: 897-916Crossref PubMed Scopus (219) Google Scholar, 23Lin C.F. Lei H.Y. Shiau A.L. Liu H.S. Yeh T.M. Chen S.H. Liu C.C. Chiu S.C. Lin Y.S. J. Immunol. 2002; 169: 657-664Crossref PubMed Scopus (161) Google Scholar, 24Lin C.F. Lei H.Y. Shiau A.L. Liu C.C. Liu H.S. Yeh T.M. Chen S.H. Lin Y.S. J. Med. Virol. 2003; 69: 82-90Crossref PubMed Scopus (162) Google Scholar). However, the exact mechanism underlying the molecular of autoantibodies is unclear. In this study, we found that the antibodies to DV induced in cross-reactive with endothelial cells and These are with studies that polyclonal antibodies against cross-reacted with endothelial cells (22Falconar A.K. Arch. Virol. 1997; 142: 897-916Crossref PubMed Scopus (219) Google Scholar, 23Lin C.F. Lei H.Y. Shiau A.L. Liu H.S. Yeh T.M. Chen S.H. Liu C.C. Chiu S.C. Lin Y.S. J. Immunol. 2002; 169: 657-664Crossref PubMed Scopus (161) Google Scholar). polyclonal antibodies from dengue patients have also been to cross-react with endothelial cells and induce endothelial cell apoptosis a (24Lin C.F. Lei H.Y. Shiau A.L. Liu C.C. Liu H.S. Yeh T.M. Chen S.H. Lin Y.S. J. Med. Virol. 2003; 69: 82-90Crossref PubMed Scopus (162) Google Scholar). These therefore, suggest the of autoantibody in dengue viral the mechanism underlying the molecular of dengue we generated many mAbs against these we identified a mAb, DB16-1, that could recognize HUVECs and human blood and this is the of a against NS1 of DV that can cross-react with human endothelial cells and and and DB16-1 could induce the apoptosis of HUVECs and cause cell by and Together, these findings suggest that DB16-1 may be involved in vascular leakage of of dengue is the mechanism of after DV We isolated the target protein of DB16-1 from HUVECs and through LC-MS/MS analysis the target protein to be human LYRIC and immunoaffinity further confirmed the target protein of DB16-1 to be human LYRIC with DB16-1 and antibodies from HUVECs and cells further that LYRIC was the target protein of DB16-1 and further LYRIC to be the target of DB16-1, we generated LYRIC protein and anti-LYRIC that DB16-1 LYRIC protein as anti-LYRIC and These findings confirmed that DB16-1 was cross-reactive with human LYRIC. LYRIC has been to be a highly conserved protein species (26Sutherland H.G. Lam Y.W. Briers S. Lamond A.I. Bickmore W.A. Exp. Cell. Res. 2004; 294: 94-105Crossref PubMed Scopus (79) Google Scholar), and has been found to be associated with the and of (25Brown D.M. Ruoslahti E. Cancer Cell. 2004; 5: 365-374Abstract Full Text Full Text PDF PubMed Scopus (326) Google Scholar, D.C. Su Z.Z. Sarkar D. Emdad L. Volsky D.J. Fisher P.B. Gene. 2005; 353: 8-15Crossref PubMed Scopus (246) Google Scholar, L. Sarkar D. Su Z.Z. A. H. K. Fisher P.B. Cancer Res. 2006; PubMed Scopus Google Scholar), although its function remains is important to the B-cell epitope of DB16-1 to identify the cross-reactive epitope in the host (17Lunardi C. Bason C. Navone R. Millo E. Damonte G. Corrocher R. Puccetti A. Nat. Med. 2000; 6: 1183-1186Crossref PubMed Scopus (244) Google Scholar, P. R. PubMed Google Scholar, P. F. G. D. A. J. Immunol. 1997; PubMed Scopus (48) Google Scholar, Lin Chiu J. Infect. Dis. 2004; PubMed Scopus (31) Google Scholar). Using phage we identified a consensus of DB16-1, in amino acid residues 116–119 in of DV NS1 proteins The phage not the bound to DB16-1 in a that with DB16-1 through its displayed of the phage The DB16-1 binding to that amino acid residues of the DV NS1 protein the B-cell epitope of the molecular of DV NS1 and we the amino acid of these both proteins contained a KXWG and this consensus was by autoantibody DB16-1 by the phage display and which corresponded to amino acid residues of human LYRIC was by DB16-1 in a the of DB16-1 to bind to could be by These that the KXWG both in amino acid residues of the DV NS1 protein and amino acid residues of human LYRIC was the B-cell epitope of DB16-1. Moreover, DB16-1 binding to human LYRIC on HUVECs and cells analysis further confirmed that DB16-1 bound to and human LYRIC through the KXWG and The of autoantibody DB16-1 binding to endothelial cells by that this and LYRIC protein may be used to prevent by sclerosis is an by vascular and against cell may be pathogenic induce endothelial cell D. J.D. J. Clin. Invest. PubMed Scopus Google Scholar, A. M. C. J.P. J. Clin. Invest. 1998; PubMed Scopus Google Scholar), the in the pathogenesis of the hCMV infection may to of systemic sclerosis through its to endothelial cells J.P. 1998; PubMed Scopus Google Scholar). molecular mechanism antibodies against the late protein UL94 to the pathogenesis of systemic sclerosis (17Lunardi C. Bason C. Navone R. Millo E. Damonte G. Corrocher R. Puccetti A. Nat. Med. 2000; 6: 1183-1186Crossref PubMed Scopus (244) Google Scholar), and of antibodies to the UL94 have been associated with (20Namboodiri A.M. Rocca K.M. Pandey J.P. Autoimmunity. 2004; 37: 241-244Crossref PubMed Scopus (31) Google Scholar). antibodies induce endothelial cell apoptosis and and have been to of systemic vascular and C. Dolcino M. Peterlana D. Bason C. Navone R. Tamassia N. Beri R. Corrocher R. Puccetti A. PLoS Med. 2006; 3: e2Crossref PubMed Scopus (91) Google Scholar). systemic sclerosis is associated with generation of pathogenetic autoantibodies by chronic infection of hCMV, the vascular permeability in dengue is the pathogenesis of DHF/DSS is and not well the clinical and of dengue infection, J. F. Rev. Med. Virol. 2006; PubMed Scopus Google Scholar), and patients with vascular permeability are and the of D.J. Clin. Microbiol. Rev. 1998; 11: 480-496Crossref PubMed Google Scholar, S. J. Med. 1987; Google Scholar, C.C. K. M.T. S. D.J. K. A. J. Med. 2005; 73: PubMed Scopus Google Scholar). In this study, we found that antibodies cross-reactive with host LYRIC protein in However, vascular permeability in human dengue infection is studies be on of human DHF different before, during, and after the onset of vascular is to the pathogenic mechanisms underlying the autoantibodies associated with conclusion, this a DB16-1, that DV NS1 and human LYRIC on Our evidence of a between NS1 of DV and human LYRIC that molecular could potentially be the mechanism underlying the development of vascular permeability a dengue IntroductionDengue virus (DV), 2The abbreviations used are: DV, dengue virus; DHF, dengue hemorrhagic fever; DSS, dengue shock syndrome; HUVEC, human umbilical vein endothelial cell; hCMV, human cytomegalovirus; NC, nitrocellulose; anti-Mid, anti-metadherin; NMIgG, normal mouse IgG. a flaviviridae, causes diseases ranging from mild dengue fever to severe syndromes, such as DHF and DSS (1Halstead S.B. Science. 1988; 239: 476-481Crossref PubMed Scopus (1292) Google Scholar, 2Gubler D.J. Clark G.G. Emerg. Infect. Dis. 1995; 1: 55-57Crossref PubMed Scopus (526) Google Scholar). Primary DV infection often leads to a painful but nonfatal dengue fever and protects patients from reinfection of DV of the same serotype. However, secondary infection with DV of a different serotype can trigger the more severe and potentially fatal DHF or DSS (1Halstead S.B. Science. 1988; 239: 476-481Crossref PubMed Scopus (1292) Google Scholar, 3Gubler D.J. Clin. Microbiol. Rev. 1998; 11: 480-496Crossref PubMed Google Scholar). The clinical presentations of DHF/DSS include thrombocytopenia, vascular leakage, hemorrhage, and complement activation. Because little is known about the pathogenic mechanisms underlying these disorders, no effective strategy has been developed to prevent their occurrence (4Bielefeldt-Ohmann H. Trends Microbiol. 1997; 5: 409-413Abstract Full Text PDF PubMed Scopus (48) Google Scholar, 5Halstead S.B. Lancet. 2007; 370: 1644-1652Abstract Full Text Full Text PDF PubMed Scopus (1164) Google Scholar).Several theories have been proposed to explain the pathogenesis of the DHF/DSS. One of them is antibody-dependent enhancement. It is theorized that upon the second infection by DV of different serotype, monocytes and/or macrophages enhance uptake of complexes of virus with non-neutralizing antibodies, subneutralizing cross-reactive antibodies, or low titer neutralizing antibodies through the Fc receptor (1Halstead S.B. Science. 1988; 239: 476-481Crossref PubMed Scopus (1292) Google Scholar, 6Halstead S.B. Venkateshan C.N. Gentry M.K. Larsen L.K. J. Immunol. 1984; 132: 1529-1532PubMed Google Scholar). Hence, the increased viral load induces the plasma leakage or hemorrhage in DHF/DSS. It has been proposed that host immune reactions, including complement activation, immune cell activation, cytokine production, and immune deviation, are involved in the initiation of DHF/DSS (7Kurane I. Innis B.L. Nisalak A. Hoke C. Nimmannitya S. Meager A. Ennis F.A. J. Clin. Invest. 1989; 83: 506-513Crossref PubMed Scopus (111) Google Scholar, 8Avirutnan P. Malasit P. Seliger B. Bhakdi S. Husmann M. J. Immunol. 1998; 161: 6338-6346PubMed Google Scholar, 9Gagnon S.J. Ennis F.A. Rothman A.L. J. Virol. 1999; 73: 3623-3629Crossref PubMed Google Scholar, 10Green S. Vaughn D.W. Kalayanarooj S. Nimmannitya S. Suntayakorn S. Nisalak A. Lew R. Innis B.L. Kurane I. Rothman A.L. Ennis F.A. J Infect. Dis. 1999; 179: 755-762Crossref PubMed Scopus (300) Google Scholar). Others suggest that viral virulence may play a role in the pathogenesis of DHF/DSS (11Rico-Hesse R. Harrison L.M. Salas R.A. Tovar D. Nisalak A. Ramos C. Boshell J. de Mesa M.T. Nogueira R.M. da Rosa A.T. Virology. 1997; 230: 244-251Crossref PubMed Scopus (521) Google Scholar, 12Diamond M.S. Edgil D. Roberts T.G. Lu B. Harris E. J. Virol. 2000; 74: 7814-7823Crossref PubMed Scopus (210) Google Scholar). However, although many theories have been put forward, the main mechanism underlying the development of DHF/DSS remains unknown.Several viruses have similar antigenic determinants that make them able to mimic host proteins (13Lane D.P. Hoeffler W.K. Nature. 1980; 288: 167-170Crossref PubMed Scopus (138) Google Scholar, 14Fujinami R.S. Oldstone M.B. Wroblewska Z. Frankel M.E. Koprowski H. Proc. Natl. Acad. Sci. U.S.A. 1983; 80: 2346-2350Crossref PubMed Scopus (247) Google Scholar), a phenomenon known as molecular mimicry. These viruses often initiate the generation of autoantibodies against the host's own tissues (15Query C.C. Keene J.D. Cell. 1987; 51: 211-220Abstract Full Text PDF PubMed Scopus (249) Google Scholar, 16Banki K. Maceda J. Hurley E. Ablonczy E. Mattson D.H. Szegedy L. Hung C. Perl A. Proc. Natl. Acad. Sci. U.S.A. 1992; 89: 1939-1943Crossref PubMed Scopus (147) Google Scholar, 17Lunardi C. Bason C. Navone R. Millo E. Damonte G. Corrocher R. Puccetti A. Nat. Med. 2000; 6: 1183-1186Crossref PubMed Scopus (244) Google Scholar). The presence of cross-reactive antibodies against endothelium after infection by human cytomegalovirus (hCMV), Epstein-Barr virus, and HIV is well documented (17Lunardi C. Bason C. Navone R. Millo E. Damonte G. Corrocher R. Puccetti A. Nat. Med. 2000; 6: 1183-1186Crossref PubMed Scopus (244) Google Scholar, 18Kaplan C. Morinet F. Cartron J. Semin. Hematol. 1992; 29: 34-44PubMed Google Scholar, 19Rhodes G.H. Valbracht J.R. Nguyen M.D. Vaughan J.H. J. Autoimmun. 1997; 10: 447-454Crossref PubMed Scopus (29) Google Scholar). The association of the autoantibody induced by hCMV infections and systemic sclerosis is a good example. The serum antibodies that induce endothelium apoptosis in patients of systemic sclerosis also recognize the late protein UL94 of hCMV (17Lunardi C. Bason C. Navone R. Millo E. Damonte G. Corrocher R. Puccetti A. Nat. Med. 2000; 6: 1183-1186Crossref PubMed Scopus (244) Google Scholar). The clinical onset of systemic sclerosis is associated with the generation of pathogenetic autoantibodies by chronic infection of hCMV (20Namboodiri A.M. Rocca K.M. Pandey J.P. Autoimmunity. 2004; 37: 241-244Crossref PubMed Scopus (31) Google Scholar, 21Lunardi C. Dolcino M. Peterlana D. Bason C. Navone R. Tamassia N. Beri R. Corrocher R. Puccetti A. PLoS Med. 2006; 3: e2Crossref PubMed Scopus (91) Google Scholar). However, vascular permeability and DHF/DSS in dengue is transient. Mouse polyclonal antibodies against DV-2 NS1 have been found able to cross-react with human endothelium (22Falconar A.K. Arch. Virol. 1997; 142: 897-916Crossref PubMed Scopus (219) Google Scholar, 23Lin C.F. Lei H.Y. Shiau A.L. Liu H.S. Yeh T.M. Chen S.H. Liu C.C. Chiu S.C. Lin Y.S. J. Immunol. 2002; 169: 657-664Crossref PubMed Scopus (161) Google Scholar). Moreover, serum antibodies from dengue fever and DHF patients can bind to HUVECs (23Lin C.F. Lei H.Y. Shiau A.L. Liu H.S. Yeh T.M. Chen S.H. Liu C.C. Chiu S.C. Lin Y.S. J. Immunol. 2002; 169: 657-664Crossref PubMed Scopus (161) Google Scholar, 24Lin C.F. Lei H.Y. Shiau A.L. Liu C.C. Liu H.S. Yeh T.M. Chen S.H. Lin Y.S. J. Med. Virol. 2003; 69: 82-90Crossref PubMed Scopus (162) Google Scholar). Once the binding occurs, endothelial cells undergo nitric oxide-mediated apoptosis (23Lin C.F. Lei H.Y. Shiau A.L. Liu H.S. Yeh T.M. Chen S.H. Liu C.C. Chiu S.C. Lin Y.S. J. Immunol. 2002; 169: 657-664Crossref PubMed Scopus (161) Google Scholar), an effect that can be blocked by recombinant NS1 protein (24Lin C.F. Lei H.Y. Shiau A.L. Liu C.C. Liu H.S. Yeh T.M. Chen S.H. Lin Y.S. J. Med. Virol. 2003; 69: 82-90Crossref PubMed Scopus (162) Google Scholar). Together, these findings suggest that the endothelial dysfunction caused by the induction of autoantibodies through host-virus interplay may be one of the factors in the pathogenesis of DHF/DSS. Understanding the molecular target of DV autoantibodies may, therefore, be important for diagnosis and the design of a suitable safe vaccine against this viral disease.In this study, we generated many anti-DV mAbs and successfully identified an anti-DV NS1 mAb, DB16-1, which was found to cross-react with HUVECs and human blood vessels. The protein targeted by DB16-1 was isolated by immunoprecipitation and designated LYRIC (lysine-rich CEACAM1 co-isolated), a finding further confirmed by mass spectrometry. LYRIC protein is also called metadherin (25Brown D.M. Ruoslahti E. Cancer Cell. 2004; 5: 365-374Abstract Full Text Full Text PDF PubMed Scopus (326) Google Scholar), 3D3 (26Sutherland H.G. Lam Y.W. Briers S. Lamond A.I. Bickmore W.A. Exp. Cell. Res. 2004; 294: 94-105Crossref PubMed Scopus (79) Google Scholar), or AEG-1 (astrocyte-elevated gene-1) (27Kang D.C. Su Z.Z. Sarkar D. Emdad L. Volsky D.J. Fisher P.B. Gene. 2005; 353: 8-15Crossref PubMed Scopus (246) Google Scholar) and is highly conserved between species (26Sutherland H.G. Lam Y.W. Briers S. Lamond A.I. Bickmore W.A. Exp. Cell. Res. 2004; 294: 94-105Crossref PubMed Scopus (79) Google Scholar). However, its biological function remains unclear. Using phage display to identify the B-cell epitope of DB16-1, we found that DV NS1 and LYRIC contained similar epitopes that may induce the production of an autoantibody. These findings suggest that DB16-1 might act as an autoantibody against LYRIC on endothelial cells and lead to the transient vascular leakage in DHF/DSS.

References

39